Atypical bacterial pneumonia and asthma risk.
Atypical bacterial pneumonia and asthma risk.
复制标题
非典型细菌性肺炎和哮喘风险。
DOI:
10.1081/jas-200038477
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Martin,RichardJ
中科院分区:
文献类型:
--
作者:
Sutherland,ERand;Brandorff,JenniferM;Martin,RichardJ
The role of respiratory infections in asthma is poorly understood. Atypical bacteriaMycoplasma pneumoniaeandChlamydia pneumoniaeare present in the lower airways of approximately 50% of asthmatics. This study tested the hypothesis that early life community‐acquired pneumonia caused byMycoplasma pneumoniaeorChlamydia pneumoniaeis associated with increased asthma prevalence. Thirty‐five subjects with a history of community‐acquired pneumonia (22 due to atypical bacteria, 13 due to nonatypical pathogens) were evaluated by questionnaire 7–9 years after the episode of pneumonia. Subjects with a history of either typical or atypical pneumonia demonstrated increased asthma prevalence. Current or past asthma prevalence was 55% in subjects with atypical bacterial pneumonia and 61.5% in subjects with nonatypical bacterial pneumonia. Significant between‐group differences were not demonstrated with regard to asthma prevalence (risk ratio = 0.89; 95% confidence interval = 0.49–1.61), current bronchodilator use [1.18 (0.44–3.17)], and family history of atopy [1.18 (0.73–1.91)], or asthma [1.63 (0.68–3.88)]. These data suggest that atypical bacterial pneumonia confers a risk of asthma similar to that seen with nonatypical bacterial pneumonia. Prospective studies are warranted to more fully evaluate the importance of atypical bacterial pneumonia as an asthma risk factor.